Literature DB >> 14747159

High frequency of defective sperm-zona pellucida interaction in oligozoospermic infertile men.

De Yi Liu1, H W Gordon Baker.   

Abstract

BACKGROUND: The ability of sperm to interact with the zona pellucida (ZP) plays a critical role during the process of human fertilization. The aim of this study is to determine frequency of defective sperm-ZP interaction in oligozoospermic infertile men.
METHODS: Sperm-ZP binding assays and the ZP-induced acrosome reaction (AR) were performed in 72 infertile men with a sperm concentration <20 x 10(6)/ml. Oocytes that had previously failed to fertilize in a clinical IVF programme were used for the tests. Motile sperm (2 x 10(6)/ml) selected by swim-up from each semen sample were incubated with four oocytes for 2 h. The number of sperm bound per ZP and the ZP-induced AR were assessed. Under these conditions, an average of < or =40 sperm bound/ZP was defined as low sperm-ZP binding and a ZP-induced AR < or =16% was defined as low ZP-induced AR.
RESULTS: In the 72 oligozoospermic men, 28% (20/72) had low sperm-ZP binding. Of those with normal sperm-ZP binding, 69% (36/52) had low ZP-induced AR. Overall, 78% (56/72) had either low ZP-binding or normal ZP binding but low ZP-induced AR. This means that only 22% (16/72) had both normal sperm-ZP binding and normal ZP-induced AR.
CONCLUSION: Oligozoospermic men have a very high frequency of defective sperm-ZP interaction, consistent with their low natural fertility or low fertilization rate in conventional IVF. Infertile couples with oligozoospermic semen should be treated by ICSI rather than by conventional IVF.

Entities:  

Mesh:

Year:  2004        PMID: 14747159     DOI: 10.1093/humrep/deh067

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Whither must spermatozoa wander? The future of laboratory seminology.

Authors:  R John Aitken
Journal:  Asian J Androl       Date:  2010-01       Impact factor: 3.285

2.  The effect of pH and viscosity on bovine spermatozoa motility under controlled conditions.

Authors:  Avez A Rizvi; Mohammed I Quraishi; Vikren Sarkar; Chris DuBois; Sinan Biro; John Mulhall
Journal:  Int Urol Nephrol       Date:  2008-11-11       Impact factor: 2.370

3.  Body mass index is not associated with sperm-zona pellucida binding ability in subfertile males.

Authors:  Nathalie Sermondade; Charlotte Dupont; Céline Faure; Marouane Boubaya; Isabelle Cédrin-Durnerin; Pascale Chavatte-Palmer; Christophe Sifer; Rachel Lévy
Journal:  Asian J Androl       Date:  2013-06-17       Impact factor: 3.285

Review 4.  Sperm function tests in clinical practice.

Authors:  Fuat Kızılay; Barış Altay
Journal:  Turk J Urol       Date:  2017-12-01

Review 5.  Secretory mechanisms and Ca2+ signaling in gametes: similarities to regulated neuroendocrine secretion in somatic cells and involvement in emerging pathologies.

Authors:  Tom Ducibella; Sara Matson
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

6.  In vitro fertilization/intracytoplasmic sperm injection for male infertility.

Authors:  Rubina Merchant; Goral Gandhi; Gautam N Allahbadia
Journal:  Indian J Urol       Date:  2011-01

7.  Significance of microRNA targeted estrogen receptor in male fertility.

Authors:  Alireza Abhari; Nosratollah Zarghami; Vahideh Shahnazi; Abolfazl Barzegar; Laya Farzadi; Hadi Karami; Sepideh Zununi Vahed; Mohammad Nouri
Journal:  Iran J Basic Med Sci       Date:  2014-02       Impact factor: 2.699

Review 8.  Hemizona assay and sperm penetration assay in the prediction of IVF outcome: a systematic review.

Authors:  Paraskevi Vogiatzi; Charalampos Chrelias; David J Cahill; Maria Creatsa; Nikos Vrachnis; Zoe Iliodromiti; Demetrios Kassanos; Charalampos Siristatidis
Journal:  Biomed Res Int       Date:  2013-10-21       Impact factor: 3.411

9.  Hepatitis B virus s protein enhances sperm apoptosis and reduces sperm fertilizing capacity in vitro.

Authors:  Jihua Huang; Ying Zhong; Xiaowu Fang; Qingdong Xie; Xiangjin Kang; Riran Wu; Fangzheng Li; Xiaoqin Xu; Hui Lu; Lan Xu; Tianhua Huang
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.